What does it do? Royal jelly is a thick, milky substance
produced by worker bees to feed the queen bee. The worker bees mix honey and bee pollen with
enzymes in the glands of their throats to produce royal jelly. Royal jelly is believed to be a
potentially useful supplement because of the queen bee’s superior size, strength,
stamina, and longevity compared to other bees, but these effects have not been studied in
humans. Royal jelly contains all of the B vitamins, including high concentrations of pantothenic acid (vitamin B5) and pyridoxine ( vitamin B6).1 Other nutritional qualities
of royal jelly are similar to those of
pollen.2
Test tube studies suggest royal jelly may have some cancer-preventive
properties.3 Animal studies have found that royal jelly has some cholesterol-lowering,4 immune-stimulating,5 anti-inflammatory, and wound-healing properties.6
Scientific investigation into the health-promoting properties of royal jelly in humans has
been limited to its ability to lower blood cholesterol levels. There have been ten human
studies published, seven of which were double-blind.7 Of these seven double-blind
studies, only three studies utilized an oral preparation of royal jelly;8
9 10 an injectable form was used in the other four.11
12 13 A detailed analysis of the oral double-blind studies concluded there
were many shortcomings in the design of the research, but royal jelly in amounts of
50–100 mg per day reduced total cholesterol levels by about 14% in people with
moderately high cholesterol levels.14
Melbrosia, a mixture of royal jelly, flower pollen, and
fermented bee pollen, was reported to help relieve
menopausal symptoms in about one-third of women in a preliminary study in
Denmark.15 This result agrees with an earlier, controlled study that found
melbrosia (amount not stated) was more effective than placebo for menopausal symptoms,
including headache, urinary incontinence, vaginal dryness, and low vitality.16
According to animal studies, melbrosia does not work by causing estrogen-like effects in body
tissues.17 Whether royal jelly alone might have similar effects on menopausal
symptoms is unknown.
References:
1. Hanza SM, Aod El-Wahab SM, Shehata MM, Mohamed TR. Investigation of
royal jelly Part I. Vitamin content of royal jelly and effect on hepatic vitamin levels in
male and female rats. Egypt J Pharm Sci 1979;20:365–73.
2. Hove Sr, Dimick PS, Benton AW. Composition of freshly harvested and
commercial royal jelly. J Apic Res 1985;24:52–61.
3. Bariliak IR, Berdyshev GD, Dugan AM. The antimutagenic action of
apiculture products. Tsitol Genet 1996;30(6):48–55 [in Russian].
4. Vittek J. Effect of royal jelly on serum lipids in experimental
animals and humans with atherosclerosis. Experientia 1995;51:927–35
[review].
5. Sver L, Orsolic N, Tadic Z, et al. A royal jelly as a new potential
immunomodulator in rats and mice. Comp Immunol Microbiol Infect Dis
1996;19:31–8.
6. Fujii A, Kobayashi S, Kuboyama N, et al. Augmentation of wound healing
by royal jelly (RJ) in streptozotocin-diabetic rats. Jpn J Pharmacol
1990;53:331–7.
7. Vittek J. Effect of royal jelly on serum lipids in experimental
animals and humans with atherosclerosis. Experientia 1995;51:927–35
[review].
8. Hammerl H, Pichler O. Zur therapie mit apifortyl. Medsche
Klin 1960;45:2015–21 [in German].
9. Madar J, Maly E, Neubauer E, Moscovic F. Einfluss des
bienenmuttervreies (gelee royale) auf den cholesterol-spiegel auf die toallipide im serum und
auf die fibrinolitische aktivitat des plasmas der an atherosklerose leidenden alteren
Menschen. Z Altersforsch 1965;18:103–8 [in German].
10. Sitar J, Cernochova Z. Treatment of angina pectoris with Vita-Apinol
Spofa. Some metabolic effects of the drug. Vnitr Lek 1967;14:1798–805.
11. Hammerl H, Pichler O. Vorlaufiger bericht uber die behandlung auf den
alternden Menschen unter besonderer berucksichtigung des cholesterin-stoffwechsels. In J
Prohyl Med Soc Hyg 1958;2:69–71 [in German].
12. Pejcev P, Chadzijev V, Mikiforov N, et al. Results of the combined
use of some bee products, honey, royal jelly and pollen to geriatric patients. Folia Med
Plovdiv 1966;8:329–33.
13. Kaczor M, Koltec A, Matuszewski J. The effect of royal jelly on blood
lipids in atheromatic patients. Polski Tygod Lek 1962;17:140–4.
14. Vittek J. Effect of royal jelly on serum lipids in experimental
animals and humans with atherosclerosis. Experientia 1995;51:927–35
[review].
15. Kristoffersen K, Thomsen BW, Schacke E, Wagner HH. Use of natural
medicines in women referred to specialists. Ugeskr Laeger 1997;159:294–6 [in
Danish].
16. Szanto E, Gruber D, Sator M, et al. Placebo-controlled study of
melbrosia in treatment of climacteric symptoms. Wien Med Wochenschr
1994;144:130–3 [in German].
17. Einer-Jensen N, Zhao J, Andersen KP, Kristoffersen K. Cimicifuga and
Melbrosia lack oestrogenic effects in mice and rats. Maturitas
1996;25:149–53.
18. Thien FCK, Leung R, Baldo BA, et al. Asthma and anaphylaxis induced
by royal jelly. Clin Exp Allergy 1996;26:216–22.
19. Leung R, Ho A, Chan J, et al. Royal jelly consumption and
hypersensitivity in the community. Clin Exp Allergy 1997;27:333–6.
20. Yonei Y, Shibagaki K, Tsukada N, et al. Case report: haemorrhagic
colitis associated with royal jelly intake. J Gastroenterol Hepatol
1997;12:495–9.
21. Takahashi M, Matsuo I, Ohkido M. Contact dermatitis due to honeybee
royal jelly. Contact Dermatitis 1983;9:452–5.